According to a new report by Polaris Market Research, the global DNA diagnostics market was valued at USD 14.07 billion in 2025 and is projected to reach USD 31.38 billion by 2034, expanding at a CAGR of 9.32% over the forecast period. Growth is underpinned by the rising prevalence of genetic disorders and cancer, a global shift toward precision medicine, and continued investment by healthcare and biotechnology companies in genomic testing infrastructure.

The DNA Diagnostics Market is advancing rapidly with the growing adoption of molecular testing, genetic analysis, and precision medicine. Improvements in sequencing technologies and diagnostic platforms are enabling faster and more accurate disease detection. The increasing integration of next generation sequencing diagnostics is emerging as a key trend, supporting personalized healthcare and expanding clinical applications.

What Is Driving DNA Diagnostics Market Growth?

Demand is climbing as expanding DNA testing services converge with rising healthcare-company investment in genomic research. Diagnostic laboratories and hospitals are prioritizing next-generation sequencing and PCR-based testing, pushing DNA diagnostics adoption across oncology, infectious disease, and reproductive health applications. Polaris analysts note that the growth of at-home testing positions the reagents and kits segment for sustained expansion through 2034, with cancer genetics tests emerging as the largest application contributor and North America posting the fastest regional CAGR.

Key Trends Shaping the DNA Diagnostics Industry

AI-Assisted Genomic Analysis

Artificial intelligence is helping labs detect disease-associated mutations faster and with greater precision by spotting complex genetic patterns that traditional methods can miss, reinforcing technology advancement across the sector.

Growth of At-Home Testing

Rising preventive-healthcare consciousness is fueling consumer interest in saliva- and cheek-swab-based testing for ancestry, carrier status, and general health insight, expanding the addressable market beyond clinical settings.

Investment in Liquid Biopsy and MRD Testing

Healthcare companies are directing capital toward non-invasive liquid biopsy and minimal residual disease (MRD) testing, a funding trend that is reshaping the competitive landscape around less invasive cancer-monitoring tools.

Market Segmentation: Breaking Down the DNA Diagnostics Market

Polaris segments the DNA diagnostics market by offering, technology, application, end-user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Offering

The market is segmented into instruments, reagents & kits, and services & software. The reagents & kits segment is projected to register a CAGR of 11.2% through 2034, driven by the launch of comprehensive testing suites that streamline sample preparation, amplification, and detection.

By Application

Cancer genetics tests held the largest revenue share at 31.6% in 2025, reflecting rising global cancer incidence and growing adoption of genomic profiling for early diagnosis. Infectious disease DNA testing and prenatal carrier screening are also expanding steadily as testing access broadens.

By Technology

Polymerase chain reaction (PCR) and next-generation sequencing (NGS) remain the dominant technology platforms, prized for combining high accuracy with increasingly practical turnaround times for both clinical and consumer testing.

By End-User

Diagnostic laboratories account for a leading end-user share, supported by scale efficiencies, while hospitals and clinics are expanding their in-house testing capacity to shorten diagnosis-to-treatment timelines.

Explore The Complete Comprehensive Report Here:

https://www.polarismarketresearch.com/industry-analysis/dna-diagnostics-market 

Regional Outlook: Where Is DNA Diagnostics Demand Growing Fastest?

Asia Pacific led the market in 2025 with a 38.7% revenue share, supported by rapid advancements in proteomics and genomics and expanding healthcare investment. North America is expected to register the fastest CAGR of 10.8% through 2034, supported by an established base of biotechnology and molecular diagnostics companies and robust research funding. Within Asia Pacific, China is projected to grow at a CAGR of 12.4%, driven by substantial healthcare-infrastructure investment; within North America, the United States remains the primary growth engine given its concentration of leading diagnostics companies.

Competitive Landscape: Leading DNA Diagnostics Companies

Key players profiled in the report include Thermo Fisher Scientific Inc., Illumina Inc., Abbott, Bio-Rad Laboratories, and QIAGEN, who are focusing on new assay launches, acquisitions, and expanded genomic-testing portfolios to strengthen market position across the reagents & kits and cancer-genetics segments outlined above. Recent moves include Abbott's March 2026 completion of its acquisition of Exact Sciences and New England Biolabs' February 2026 launch of a scalable cell-free DNA extraction kit, both aimed at deepening share in cancer-screening and liquid-biopsy applications.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching genomic and molecular diagnostics suppliers, this report benchmarks market share, segment-level pricing, and forecast data — by offering, technology, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking at-home genetic testing as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Razor Market

Macadamia Market

Virtual Power Plant Market

Petrochemicals Market

Octyl Alcohol Market

Octyl Alcohol Market

Sandfish Market

Automotive Market

Protein Ice Cream Market